Clinical Trials
3 trialsNCT03031938 2021-06-25
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies
Pfizer
Phase 3 Completed
NCT02367820 2021-06-22
SUMMIT-LTS
Nektar Therapeutics
Phase 3 Completed
NCT00904280 2009-05-19
Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy
Endo Pharmaceuticals
Phase 3 Completed